Kate W. Email

Senior Director Project Management . MoonLake Immunotherapeutics (NASDAQ MLTX)

Current Roles

Employees:
111
Revenue:
$10.4M
About
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
MoonLake Immunotherapeutics (NASDAQ MLTX) Address

Zug, null
Switzerland
MoonLake Immunotherapeutics (NASDAQ MLTX) Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.